Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
Clinical trial NCT01997229 · COMPLETED
Trial details
- NCT number
- NCT01997229
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-02-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.